COSMOS Pharmaceutical (TSE:3349) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3349 COSMOS Pharmaceutical Corp TSE:3349
89 GF Score
Price 円6,436.00
GF Value 円8,544.31
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is COSMOS Pharmaceutical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


COSMOS Pharmaceutical  (TSE:3349) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Related Terms


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Chart

COSMOS Pharmaceutical Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.85 0.73 0.91 0.57

COSMOS Pharmaceutical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.89 0.73 0.67 0.56

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio falls into.


TSE:3349
89GF Score
COSMOS Pharmaceutical Corp TSE:3349
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in May. 2026 is calculated as:

For example, COSMOS Pharmaceutical's adjusted Revenue per Share data for the three months ended in May. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of May. 2026 (Change)*Current CPI (May. 2026)
=3648.915/113.5000*113.5000
=3,648.915

Current CPI (May. 2026) = 113.5000.

COSMOS Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201608 1,598.240 97.900 1,852.914
201611 1,521.069 98.600 1,750.926
201702 1,559.668 98.100 1,804.509
201705 1,668.786 98.600 1,920.966
201708 1,751.629 98.500 2,018.375
201711 1,668.079 99.100 1,910.464
201802 1,766.907 99.500 2,015.517
201805 1,858.980 99.300 2,124.816
201808 1,938.603 99.800 2,204.724
201811 1,828.803 100.000 2,075.691
201902 1,920.686 99.700 2,186.538
201905 2,028.454 100.000 2,302.295
201908 2,077.066 100.000 2,357.470
201911 2,029.956 100.500 2,292.537
202002 2,116.309 100.300 2,394.826
202005 2,418.311 100.100 2,742.041
202008 2,388.451 100.100 2,708.184
202011 2,209.823 99.500 2,520.753
202102 2,241.491 99.800 2,549.191
202105 2,332.465 99.400 2,663.328
202108 2,391.584 99.700 2,722.616
202111 2,294.615 100.100 2,601.786
202202 2,370.606 100.700 2,671.934
202205 2,481.495 101.800 2,766.696
202208 2,602.623 102.700 2,876.317
202211 2,498.734 103.900 2,729.608
202302 2,554.190 104.000 2,787.505
202305 2,795.472 105.100 3,018.897
202308 3,051.262 105.900 3,270.238
202311 2,963.025 106.900 3,145.962
202402 3,013.979 106.900 3,200.062
202405 3,150.208 108.100 3,307.573
202408 3,303.673 109.100 3,436.910
202411 3,079.778 110.000 3,177.771
202502 3,108.003 110.800 3,183.740
202505 3,269.376 111.800 3,319.089
202508 3,436.833 112.100 3,479.755
202511 3,340.779 113.200 3,349.633
202602 3,447.066 112.200 3,487.005
202605 3,648.915 113.500 3,648.915

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is COSMOS Pharmaceutical (TSE:3349) Overvalued in 2026?

Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued. The current stock price of 円6,436.00 is trading 24.7% below its estimated GF Value™ of 円8,544.31. GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.

Key valuation signals for TSE:3349:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円8,544.31 vs. price of 円6,436.00 (24.7% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the TSE:3349 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


COSMOS Pharmaceutical Business Description

Other Exchanges CSMYF:USA
Address 10-1 Hakataeki Higashi 2-chome, 4th floor, JR Hakata Station East NS Building S, Hakata-ku, Fukuoka Prefecture, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
89GF Score

Get the complete analysis for TSE:3349

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,436.00
Price
円8,544.31
GF Value